>

Fc receptor (CD32)

Q: Can I use the Fc receptor (CD32) icon in a BioRender figure or scientific illustration?

Yes — the Fc receptor (CD32) is fully integrated into BioRender's drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you're building from scratch or starting with a BioRender template.

Q: Can I export figures that include the Fc receptor (CD32) icon for publication or presentations?

Yes — figures containing the Fc receptor (CD32) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

Fc receptor (CD32) - Editable icon of CD32 Fc receptor with α-chain of two extracellular Ig-like domains and intracellular ITAM or ITIM domain

[{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7fc/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7fc/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7fb/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7fb/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7fa/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7fa/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f9/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f9/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f8/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f8/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f7/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f7/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f6/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f6/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f5/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f5/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f4/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f4/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f3/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f3/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f2/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f2/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f1/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f1/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f0/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f0/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7ef/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7ef/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7ee/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7ee/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7ed/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7ed/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7ec/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7ec/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7eb/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7eb/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7ea/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7ea/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e9/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e9/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e8/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e8/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e7/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e7/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e6/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e6/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e5/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e5/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e4/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e4/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e3/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e3/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e2/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e2/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e1/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e1/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e0/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e0/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7df/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7df/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7de/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7de/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7dd/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7dd/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7dc/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7dc/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7db/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7db/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7da/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7da/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7d9/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7d9/5fe111953bc6e50027a6f7d8.png"}]

Keywords

keyword text

CD32,Fc receptor,Fc region,FcγRIIA,FcγRII,α-chain,alpha chain,α chain,alpha-unit,Ig-like,Ig like,immunoglobin-like,ITAM,ITIM,CD32

BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More

More Icons like this one in

Related Categories

Back To Library Home

Join 1,500,000 other scientists on BioRender

Sign up for your free account and start creating scientific figures faster today

Sign Up Free

FAQs

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Fc receptor (CD32) icon along with our library of more than 30,000 life science icons.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the Fc receptor (CD32) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Fc receptor (CD32) icon customizable in BioRender?

Most icons in BioRender, including the Fc receptor (CD32) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

How are scientists using the Fc receptor (CD32) icon in their work?

BioRender users often use the Fc receptor (CD32) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Proteins.

Can I export figures that include the Fc receptor (CD32) icon for publication or presentations?

Yes, figures containing the Fc receptor (CD32) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

Is the Fc receptor (CD32) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Fc receptor (CD32) icon — especially those focused on Proteins. You can search BioRender’s template library or add this icon manually to any canvas.

Make scientific figures in minutes

Fc receptor (CD32)

Join 1,500,000 other scientists on BioRender

FAQs

Looking for science content?